Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Welcome!
CDPH Training – March 19, 2015
What we will cover today
• Intros
• Overview ARV-based prevention
• Understanding PrEP
– What is PrEP?
– PrEP research
– H...
Ground rules
• We are all here to learn
• The only dumb questions are the
ones not asked
• Listen actively, respect others...
4
5
What is the first word or
words that come to your
mind when you think
about condoms?
6
What is the first word or
words that come to your
mind when you think about
needle exchange?
7
What is the first word or
words that come to your
mind when you think about
oral contraceptives?
8
What is the first word or
words that come to your
mind when you think
about PrEP?
9
10
• Sex without condoms does not automatically
= “unprotected sex.”
• Will no longer frame sex without condoms as
“unprotect...
12
What is ARV-based prevention?
• Strategies that use HIV treatment
drugs (antiretrovirals or “ARVs”) to
prevent HIV infecti...
14
15
Hold up, what is prophylaxis?
• Prophylaxis is simply the provision of
medications prior to germ or virus
exposure to prev...
17
18
What is PreP?
• PrEP consists of taking the ARV drug Truvada to
prevent HIV*
• Truvada is a combination of tenofovir disop...
• Truvada is approved for use as part of a comprehensive HIV
prevention strategy that includes other prevention methods,
s...
Released May 14, 2014
21
tinyurl.com/CDCprepguidelines (PDF)
tinyurl.com/CDCprepguidelineswebinar
(webinar audio/slides)
PrEP Clinical Practice Guideline
• For clinicians
– But incredibly useful for providers, educators, policy
folks, and advo...
23
Ken Like Barbie explains
PrEP
24
Ken Like Barbie recap
• PrEP involves HIV-neg person
taking ARVs to reduce risk of
infection before HIV exposure.
• PrEP p...
www.myprepexperience.org
27
28
PrEP is more than a prescription
PrEP is a
program
 Provider* visits every 3 mos
 HIV testing
 Tied to Rx renewal
 Hepatitis B testing
 Kidney function testing
 STI sc...
 It’s not just a pill, it’s a program
 Adherence (perfection not
required, esp for rectal)
 Take 5 – 7 days* before
eno...
• iPrEX Open Label
• 1,603 participants, 1,225 on PrEP
• Most from Peru/Ecuador, 18% USA
• 100% effectiveness associated
w...
32
You can miss a dose here and there and still have excellent protection.
33
Adherence is a much bigger deal for vaginal protection.
What PrEP does not do
• Truvada as PrEP does not
– Guarantee 100% protection from HIV (what
does?)
– Protect a person agai...
35
• True or False: PrEP must be started within 72 hours
of exposure to HIV.
• What is an example of “prophylaxis?”
• The ...
36
37
38
39
40
Science.
Science
• All completed trials done on tenofovir &
Truvada
• 4 trials = PrEP reduced risk of HIV infection
– i-PrEX (Truva...
Bumps in the road for women
• 2 trials = PrEP did not work
– FEM-PrEP (Truvada in women –
stopped 2011)
– VOICE (Truvada, ...
Key research findings
• Adherence!
• High adherence achieved 90%+
reduction in risk
• Truvada PrEP trials to date have
not...
Key research findings
• Some will experience a general “start-up
syndrome” w/Truvada that includes nausea,
diarrhea, abdom...
Side effects
• 1 in 10 will have nausea that
subsides quickly.
• 1 in 100 will experience bone
density loss, which plateau...
46
47
48
PrEP’s “protease moment”
49
PROUD – 86%
IPERGAY – 86%
PARTNERS DEMO – 96%
croiconference.org
50
There is an urgent need to mobilize clinical
efforts, service delivery, education,
implementation research, and policy ...
PROUD – London
51
52
PROUD – London
53
PROUD – London
Daily PrEP works in the real world.
Quite well! It was easily incorporated
into sexual health clinics. R...
54
Ipergay – France, Canada
55
Ipergay – France, Canada
56
Ipergay – France, Canada
57
Ipergay – France, Canada
Challenges our daily adherence
messaging. Only applicable to
gay men and rectums. And what
do ...
58
Partners Demo – Kenya, Uganda
59
Partners Demo – Kenya, Uganda
60
Partners Demo – Kenya, Uganda
61
Partners Demo – Kenya, Uganda
62
Partners Demo – Kenya, Uganda
63
Partners Demo – Kenya, Uganda
64
Partners Demo – Kenya, Uganda
PrEP and TasP are synergistic and can be
combined programmatically. Shared
responsibility...
65
66
• True or False: PrEP does not work for women.
• True or False: About 25% of people who take
PrEP will have nausea.
• T...
67
www.myprepexperience.org
Who might be a good fit for PrEP?
• Person indicates an interest in taking PrEP
• Person is in a “magnetic” relationship
–...
Who might be a good fit for PrEP?
• Sexual activity within high prevalence area or social
network, and/or:
– Doesn’t use m...
Truvada as PrEP
Is the first non-
barrier HIV
prevention strategy
fully controlled by
the receptive
partner.
71
pleasure
intimacy
connection
emotion
lust
love
74
In this sample of men
who are in a
relationship with a
perceived HIV-negative
man, we found that
intimacy motivation wa...
75
Reclaim
pleasure
THOUGHTFUL
RESPONSIBLE
CAREFUL
AWARE
PRO-ACTIVE
DISCIPLINED
TAKING PREP IS
SAFER SEX
TAKING PREP IS
78
79
Accessing PrEP in Chicago
• Any medical provider who can
write a scrip can write one for
Truvada as PrEP
• Most HIV docs f...
81
82
Uninformed, misinformed providers
84
Handy brochure
85
Designed to help individuals talk to
their doctors about PrEP
Before, during, after visit
Questions to...
86
PrEPline, 855-448-7737
The CCC Pre-Exposure Prophylaxis Service
11 a.m. – 6 p.m. EST
http://nccc.ucsf.edu/2014/09/29/in...
• MyPrEPexperience.org
• Facebook group – PrEP Facts
• Facebook.com/ProjectRSP (Ready, Set, PrEP)
• PrEPWatch.org (advocac...
Groovy PrEP videos
88
WhatisPrEP.org
tinyurl.com/PrEPbyKLB
89
Drug cost
Service costs
Lab costs
Paying for PrEP— insurance
FDA approval of
Truvada enables
private ins to cover
Truvada
on
Medicaid
formulary
Ins companie...
94
the devil is in the details
95
the devil is in the details
Paying for PrEP – Gilead
1. Visit
www.truvada.com
2. Click on the link to
access information
about Truvada for a
PrEP indi...
Medication assistance
• Gilead will provide Truvada for PrEP at no cost for
individuals who qualify for the assistance pro...
Co-pay card program
Covers all Gilead HIV Products: Stribild, Complera,
Atripla, Truvada, Viread, Emtriva
• Assists patien...
Paying for PrEP – Illinois
99
PrEP4Illinois.com
100
101
• Accepting applications for new and renewal
patients. If application for assistance is
approved can begin receiving f...
102
• Insured, insurance must cover
medication for which patient seeks
assistance
• Patient must reside and receive
treatm...
103
104
USCA 2014
105
• How can people pay for their PrEP
prescriptions?
• People taking PrEP need to be tested for HIV
_____ times every ye...
106
107
Baggage
108
109
110
“Party drug”
“Public health disaster”
111
112
Condom privilege
113
114
ARVs are toxic
115
“Although
pre-exposure
prophylaxis has a
great potential in reducing incidence, scale-up
might be inhibited by the same so...
117
More focus, More energy and
More resources 118
119
Messages to emphasize to clients
• PrEP is an option
– Not forever, but maybe for a “season”
– If you use condoms successf...
Tips for talking about PrEP
• Important you feel comfortable and
confident talking about PrEP.
• It’s okay to not have all...
Tips for talking about PrEP
• As a provider, you are viewed as a trusted source
of information.
• Remember any perspective...
PrEP elevator speech
• You get in the elevator at the 95th floor with
someone who has just asked you about PrEP.
You have ...
124
• If someone doesn’t use ________
regularly, they may be a good fit for PrEP.
• PrEP is not just a pill, it’s a ______...
125
Chicago PrEP
Working
Group
Researchers
Medical
providers
Advocates
Orgs/HDs
HIV planning
members
126
Chicago PrEP
Working
Group
Researchers
Medical
providers
Advocates
CBOs
HIV planning
members
127
Chicago PrEP
Working
Group
Researchers
Medical
providers
Advocates
CBOs
HIV planning
members
128
129
1000’s
NEW
HIV prevention
advocates
135
136
137
138
139
140
141
Thank you!!
142
143
CONTACT
Jim Pickett
jpickett@aidschicago.org
Sara Semelka
ssemelka@aidschicago.org
144
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)
Project RSP! training on PrEP for the HIV workforce (March 19, 2015)
Upcoming SlideShare
Loading in …5
×

of

Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 1 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 2 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 3 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 4 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 5 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 6 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 7 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 8 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 9 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 10 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 11 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 12 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 13 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 14 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 15 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 16 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 17 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 18 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 19 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 20 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 21 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 22 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 23 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 24 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 25 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 26 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 27 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 28 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 29 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 30 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 31 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 32 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 33 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 34 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 35 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 36 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 37 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 38 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 39 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 40 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 41 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 42 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 43 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 44 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 45 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 46 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 47 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 48 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 49 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 50 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 51 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 52 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 53 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 54 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 55 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 56 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 57 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 58 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 59 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 60 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 61 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 62 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 63 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 64 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 65 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 66 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 67 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 68 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 69 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 70 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 71 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 72 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 73 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 74 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 75 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 76 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 77 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 78 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 79 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 80 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 81 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 82 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 83 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 84 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 85 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 86 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 87 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 88 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 89 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 90 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 91 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 92 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 93 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 94 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 95 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 96 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 97 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 98 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 99 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 100 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 101 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 102 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 103 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 104 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 105 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 106 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 107 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 108 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 109 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 110 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 111 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 112 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 113 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 114 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 115 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 116 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 117 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 118 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 119 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 120 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 121 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 122 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 123 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 124 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 125 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 126 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 127 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 128 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 129 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 130 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 131 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 132 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 133 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 134 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 135 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 136 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 137 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 138 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 139 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 140 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 141 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 142 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 143 Project RSP! training on PrEP for the HIV workforce (March 19, 2015) Slide 144
Upcoming SlideShare
Encore Marketing Presentation
Next
Download to read offline and view in fullscreen.

1 Like

Share

Download to read offline

Project RSP! training on PrEP for the HIV workforce (March 19, 2015)

Download to read offline

This training on PrEP for HIV prevention was conducted by AIDS Foundation of Chicago (AFC) in collaboration with the Chicago Department of Public Health on March 19, 2015. These slides comprise a 3.5 hour training designed for people in the HIV workforce in Chicago and throughout Illinois that AFC and partners conduct at various times in the year. They are continually updated - this presentation includes recent PrEP data presented at CROI 2015 in late February.

Related Books

Free with a 30 day trial from Scribd

See all

Related Audiobooks

Free with a 30 day trial from Scribd

See all

Project RSP! training on PrEP for the HIV workforce (March 19, 2015)

  1. 1. Welcome! CDPH Training – March 19, 2015
  2. 2. What we will cover today • Intros • Overview ARV-based prevention • Understanding PrEP – What is PrEP? – PrEP research – How PrEP is taken – Access to PrEP – Talking to clients about PrEP 2
  3. 3. Ground rules • We are all here to learn • The only dumb questions are the ones not asked • Listen actively, respect others when they are talking • Participate to the fullest of our abilities 3
  4. 4. 4
  5. 5. 5
  6. 6. What is the first word or words that come to your mind when you think about condoms? 6
  7. 7. What is the first word or words that come to your mind when you think about needle exchange? 7
  8. 8. What is the first word or words that come to your mind when you think about oral contraceptives? 8
  9. 9. What is the first word or words that come to your mind when you think about PrEP? 9
  10. 10. 10
  11. 11. • Sex without condoms does not automatically = “unprotected sex.” • Will no longer frame sex without condoms as “unprotected.” – Protection can mean VL suppression, it can mean sero-adaptation, and it can mean PrEP (in addition to male and female condoms) 11 Protection w/out condoms
  12. 12. 12
  13. 13. What is ARV-based prevention? • Strategies that use HIV treatment drugs (antiretrovirals or “ARVs”) to prevent HIV infection – TLC+ (testing, linkage to care, plus treatment) – ARV-based microbicides – PEP (post-exposure prophylaxis) – PrEP (pre-exposure prophylaxis) 13
  14. 14. 14
  15. 15. 15
  16. 16. Hold up, what is prophylaxis? • Prophylaxis is simply the provision of medications prior to germ or virus exposure to prevent infection. • This is not a new concept. • This is not a new practice. • Example: taking malaria drugs before traveling to countries with high malaria incidence • What are examples of similar concepts? 16
  17. 17. 17
  18. 18. 18
  19. 19. What is PreP? • PrEP consists of taking the ARV drug Truvada to prevent HIV* • Truvada is a combination of tenofovir disoproxil fumarate (aka tenofovir or TDF) and emtricitabine. • Need to take 5 – 7 days* of Truvada before enough drug is “on board” for protection in rectum. • Three weeks for vaginal protection. • Truvada is currently the only drug approved by the FDA for PrEP. *A moving target, as we will see….. 19
  20. 20. • Truvada is approved for use as part of a comprehensive HIV prevention strategy that includes other prevention methods, such as safe sex practices, risk reduction counseling, and regular HIV testing. - FDA – Must be confirmed HIV-negative before prescription – FDA required development of Risk Evaluation and Mitigation Strategy (REMS) for use of Truvada as PrEP to ensure safe use • www.truvadapreprems.com • Medication guide • Community education • Provider training • Implementation Dateline: July 16, 2012 20
  21. 21. Released May 14, 2014 21 tinyurl.com/CDCprepguidelines (PDF) tinyurl.com/CDCprepguidelineswebinar (webinar audio/slides)
  22. 22. PrEP Clinical Practice Guideline • For clinicians – But incredibly useful for providers, educators, policy folks, and advocates – YOU • Includes info on efficacy and safety evidence, guidelines for screening, providing PrEP to gay men, heterosexuals, and injection drug users, discontinuing PrEP, clinical considerations, improving adherence, reducing risk behaviors, info on financial case management, fact sheets, risk index, counseling info, and quality measures 22
  23. 23. 23 Ken Like Barbie explains PrEP
  24. 24. 24
  25. 25. Ken Like Barbie recap • PrEP involves HIV-neg person taking ARVs to reduce risk of infection before HIV exposure. • PrEP prevents HIV from reproducing in a person’s body. • In current approved form, PrEP is taken in a single pill – Truvada –once a day, every day 25
  26. 26. www.myprepexperience.org
  27. 27. 27
  28. 28. 28 PrEP is more than a prescription PrEP is a program
  29. 29.  Provider* visits every 3 mos  HIV testing  Tied to Rx renewal  Hepatitis B testing  Kidney function testing  STI screening  Pregnancy testing  Adherence counselling  Honest, open discussions about sex, sexual health 29 Taking PrEP…. what does it take? *These activities don’t all need to be done by a doctor in their office
  30. 30.  It’s not just a pill, it’s a program  Adherence (perfection not required, esp for rectal)  Take 5 – 7 days* before enough drug is “on board” to provide protection in the rectum, 3 weeks for the vagina  Then take Truvada every day 30 *This is a moving target, as we will see….. Taking PrEP…. what does it take?
  31. 31. • iPrEX Open Label • 1,603 participants, 1,225 on PrEP • Most from Peru/Ecuador, 18% USA • 100% effectiveness associated with 4+ doses a week (rectal) • 84% effectiveness in ppl who took 2 -3 doses a week • Ppl engaging in higher risk sex self-selected for PrEP • Adherence issues more pronounced among young people 31
  32. 32. 32 You can miss a dose here and there and still have excellent protection.
  33. 33. 33 Adherence is a much bigger deal for vaginal protection.
  34. 34. What PrEP does not do • Truvada as PrEP does not – Guarantee 100% protection from HIV (what does?) – Protect a person against other STIs like chlamydia, syphilis, or gonorrhoea – Prevent pregnancy – Cure HIV – Function as a treatment regimen for someone already living with HIV. 34
  35. 35. 35 • True or False: PrEP must be started within 72 hours of exposure to HIV. • What is an example of “prophylaxis?” • The FDA approved Truvada as PrEP in what year? • True or False: It takes longer for PrEP to achieve protection in the vagina compared to the rectum.
  36. 36. 36
  37. 37. 37
  38. 38. 38
  39. 39. 39
  40. 40. 40 Science.
  41. 41. Science • All completed trials done on tenofovir & Truvada • 4 trials = PrEP reduced risk of HIV infection – i-PrEX (Truvada in gay men and trans women) – Partners PrEP (Truvada and tenofovir in heterosexual couples) • TDF/FTC combination and Tenofovir alone comparably efficacious – TDF2 (Truvada heterosexual men & women) – Bangkok Tenofovir Study (injection drug users) 41
  42. 42. Bumps in the road for women • 2 trials = PrEP did not work – FEM-PrEP (Truvada in women – stopped 2011) – VOICE (Truvada, tenofovir – reported 2013) • Both trials had very low adherence – (though self-reports were high) • Both trials found low/undetected drug levels • Important to note – PrEP does work for women, and the FDA prevention indication includes women 42
  43. 43. Key research findings • Adherence! • High adherence achieved 90%+ reduction in risk • Truvada PrEP trials to date have not shown increases in sexual risk behavior among participants • Across all PrEP studies of Truvada, there have been no serious safety problems 43
  44. 44. Key research findings • Some will experience a general “start-up syndrome” w/Truvada that includes nausea, diarrhea, abdominal pain and headaches. • Nausea most common (under 10%) and resolved in 4 to 6 weeks. • Very little drug resistance has been seen, only among those with unidentified HIV infection when they started the study. 44
  45. 45. Side effects • 1 in 10 will have nausea that subsides quickly. • 1 in 100 will experience bone density loss, which plateaus and doesn’t progress. Not usually clinically significant. • 1 in 200 will experience kidney problems, which resolve after stopping. Can be safe to re-start. 45
  46. 46. 46
  47. 47. 47
  48. 48. 48
  49. 49. PrEP’s “protease moment” 49 PROUD – 86% IPERGAY – 86% PARTNERS DEMO – 96% croiconference.org
  50. 50. 50 There is an urgent need to mobilize clinical efforts, service delivery, education, implementation research, and policy to optimize PrEP access and use. – Dr. Raphael Landovitz/UCLA croiconference.org
  51. 51. PROUD – London 51
  52. 52. 52 PROUD – London
  53. 53. 53 PROUD – London Daily PrEP works in the real world. Quite well! It was easily incorporated into sexual health clinics. Results only applicable to gay men.
  54. 54. 54 Ipergay – France, Canada
  55. 55. 55 Ipergay – France, Canada
  56. 56. 56 Ipergay – France, Canada
  57. 57. 57 Ipergay – France, Canada Challenges our daily adherence messaging. Only applicable to gay men and rectums. And what do we really know about men having infrequent sex?
  58. 58. 58 Partners Demo – Kenya, Uganda
  59. 59. 59 Partners Demo – Kenya, Uganda
  60. 60. 60 Partners Demo – Kenya, Uganda
  61. 61. 61 Partners Demo – Kenya, Uganda
  62. 62. 62 Partners Demo – Kenya, Uganda
  63. 63. 63 Partners Demo – Kenya, Uganda
  64. 64. 64 Partners Demo – Kenya, Uganda PrEP and TasP are synergistic and can be combined programmatically. Shared responsibility is important aspect. Works in resource challenged settings. Applicable to hetero women and men.
  65. 65. 65
  66. 66. 66 • True or False: PrEP does not work for women. • True or False: About 25% of people who take PrEP will have nausea. • True or False: Regular STD screening is part of the PrEP program. • True or False: You don’t need to adhere perfectly to PrEP to achieve high levels of protection.
  67. 67. 67
  68. 68. www.myprepexperience.org
  69. 69. Who might be a good fit for PrEP? • Person indicates an interest in taking PrEP • Person is in a “magnetic” relationship –HIV-negative and has HIV+ partner 69
  70. 70. Who might be a good fit for PrEP? • Sexual activity within high prevalence area or social network, and/or: – Doesn’t use male or female condoms consistently – Diagnosed with STI(s) – Exchanges sex for money, food, shelter, drugs, etc. – Uses illicit drugs or depends on alcohol – Is or has been incarcerated – Does not know partner’s HIV status and one of the above factors is true for partner – Injects drugs one or more times daily – Shares injection equipment – Injects cocaine or meth 70
  71. 71. Truvada as PrEP Is the first non- barrier HIV prevention strategy fully controlled by the receptive partner. 71
  72. 72. pleasure intimacy connection emotion lust love
  73. 73. 74 In this sample of men who are in a relationship with a perceived HIV-negative man, we found that intimacy motivation was the strongest predictor of adopting PrEP. “Intimacy Motivations and Pre-exposure Prophylaxis (PrEP) Adoption Intentions Among HIV-Negative Men Who Have Sex with Men (MSM) in Romantic Relationships” – Annals of Behavioral Medicine August 2014
  74. 74. 75 Reclaim pleasure
  75. 75. THOUGHTFUL RESPONSIBLE CAREFUL AWARE PRO-ACTIVE DISCIPLINED TAKING PREP IS
  76. 76. SAFER SEX TAKING PREP IS
  77. 77. 78
  78. 78. 79
  79. 79. Accessing PrEP in Chicago • Any medical provider who can write a scrip can write one for Truvada as PrEP • Most HIV docs familiar with PrEP • CORE Center • UC and ACCESS Grand Blvd • Howard Brown Health Center • Chicago PrEP Working Group 80
  80. 80. 81
  81. 81. 82
  82. 82. Uninformed, misinformed providers
  83. 83. 84
  84. 84. Handy brochure 85 Designed to help individuals talk to their doctors about PrEP Before, during, after visit Questions to ask Web resources tinyurl.com/talkPrEPtoDr
  85. 85. 86 PrEPline, 855-448-7737 The CCC Pre-Exposure Prophylaxis Service 11 a.m. – 6 p.m. EST http://nccc.ucsf.edu/2014/09/29/introducing-the-ccc-prepline/ PrEP Warm Line
  86. 86. • MyPrEPexperience.org • Facebook group – PrEP Facts • Facebook.com/ProjectRSP (Ready, Set, PrEP) • PrEPWatch.org (advocacy) • ProjectInform.org/prep • Truvada.com (Gilead) • WhatisPrEP.org (video) Web resources on PrEP 87
  87. 87. Groovy PrEP videos 88 WhatisPrEP.org tinyurl.com/PrEPbyKLB
  88. 88. 89
  89. 89. Drug cost
  90. 90. Service costs
  91. 91. Lab costs
  92. 92. Paying for PrEP— insurance FDA approval of Truvada enables private ins to cover Truvada on Medicaid formulary Ins companies covering, so far ADAP does not cover PrEP 93
  93. 93. 94 the devil is in the details
  94. 94. 95 the devil is in the details
  95. 95. Paying for PrEP – Gilead 1. Visit www.truvada.com 2. Click on the link to access information about Truvada for a PrEP indication 96
  96. 96. Medication assistance • Gilead will provide Truvada for PrEP at no cost for individuals who qualify for the assistance program Program Element Truvada PrEP Medication Assistance Program Eligibility Criteria US resident, uninsured or no drug coverage, HIV- negative, low income (500% FPL) Drug Fulfillment Product dispensed by Covance Specialty Pharmacy, labeled for individual patient use and shipped to prescriber (30 day supply); no card or voucher option Recertification Period 6 months, with 90 day status check 9797
  97. 97. Co-pay card program Covers all Gilead HIV Products: Stribild, Complera, Atripla, Truvada, Viread, Emtriva • Assists patients with commercial insurance who reside in the US, or US Territories • Not valid for Rx that are eligible to be reimbursed by any federal or state funded healthcare benefit program • Co-pay benefit provides assistance for co-pays above $0 • Monthly benefit provided for 12 mos after activation of card – $400/month for all STRs (Stribild, Complera, Atripla) – $300/month for (Truvada, Viread, Emtriva) • No maximum lifetime benefit but pts need to recertify after 12 months
  98. 98. Paying for PrEP – Illinois 99 PrEP4Illinois.com
  99. 99. 100
  100. 100. 101 • Accepting applications for new and renewal patients. If application for assistance is approved can begin receiving funding immediately • Maximum Award Level – $4,000 per year. • Patients may apply for second grant during eligibility period subject to funding availability Paying for PrEP – PAN Foundation
  101. 101. 102 • Insured, insurance must cover medication for which patient seeks assistance • Patient must reside and receive treatment in U.S • Patient’s income below 500% of the Federal Poverty Level www.panfoundation.org/hiv-treatment-and-prevention PAN Foundation Eligibility
  102. 102. 103
  103. 103. 104 USCA 2014
  104. 104. 105 • How can people pay for their PrEP prescriptions? • People taking PrEP need to be tested for HIV _____ times every year. • Why is this important? • Name one barrier to PrEP access.
  105. 105. 106
  106. 106. 107
  107. 107. Baggage 108
  108. 108. 109
  109. 109. 110 “Party drug” “Public health disaster”
  110. 110. 111
  111. 111. 112 Condom privilege
  112. 112. 113
  113. 113. 114 ARVs are toxic
  114. 114. 115
  115. 115. “Although pre-exposure prophylaxis has a great potential in reducing incidence, scale-up might be inhibited by the same social or structural barriers to care outcomes for black MSM with HIV.” 116 Understanding the HIV disparities between black and white men who have sex with men in the USA using the HIV care continuum: a modelling study The Lancet HIV, December 2014 doi:10.1016/S2352-3018(14)00011-3 Rosenberg, Millett, Sullivan, del Rio, Curran MD
  116. 116. 117
  117. 117. More focus, More energy and More resources 118
  118. 118. 119
  119. 119. Messages to emphasize to clients • PrEP is an option – Not forever, but maybe for a “season” – If you use condoms successfully, do you need PrEP? • It’s not just a pill, it’s a program. – Holistic health care • Person must test HIV-negative to initiate and continue PrEP. • Adherence. Different for men and women. • Ipergay – complexities, complications. 120
  120. 120. Tips for talking about PrEP • Important you feel comfortable and confident talking about PrEP. • It’s okay to not have all of the answers and to refer your client to additional resources and/or promise to have that information next time you see him/her. 121
  121. 121. Tips for talking about PrEP • As a provider, you are viewed as a trusted source of information. • Remember any perspectives/opinions you have about PrEP and/or people who use PrEP will translate to your clients. 122
  122. 122. PrEP elevator speech • You get in the elevator at the 95th floor with someone who has just asked you about PrEP. You have until ground level to explain it to them. »What do you say? • Take a few moments to think • Volunteers to share? 123
  123. 123. 124 • If someone doesn’t use ________ regularly, they may be a good fit for PrEP. • PrEP is not just a pill, it’s a _________. • Beyond a prescription, what is involved with taking PrEP?
  124. 124. 125
  125. 125. Chicago PrEP Working Group Researchers Medical providers Advocates Orgs/HDs HIV planning members 126
  126. 126. Chicago PrEP Working Group Researchers Medical providers Advocates CBOs HIV planning members 127
  127. 127. Chicago PrEP Working Group Researchers Medical providers Advocates CBOs HIV planning members 128
  128. 128. 129
  129. 129. 1000’s NEW HIV prevention advocates
  130. 130. 135
  131. 131. 136
  132. 132. 137
  133. 133. 138
  134. 134. 139
  135. 135. 140
  136. 136. 141
  137. 137. Thank you!! 142
  138. 138. 143
  139. 139. CONTACT Jim Pickett jpickett@aidschicago.org Sara Semelka ssemelka@aidschicago.org 144
  • zahernourredine

    Dec. 9, 2018

This training on PrEP for HIV prevention was conducted by AIDS Foundation of Chicago (AFC) in collaboration with the Chicago Department of Public Health on March 19, 2015. These slides comprise a 3.5 hour training designed for people in the HIV workforce in Chicago and throughout Illinois that AFC and partners conduct at various times in the year. They are continually updated - this presentation includes recent PrEP data presented at CROI 2015 in late February.

Views

Total views

874

On Slideshare

0

From embeds

0

Number of embeds

5

Actions

Downloads

17

Shares

0

Comments

0

Likes

1

×